SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-023265
Filing Date
2019-06-24
Accepted
2019-06-24 17:00:20
Documents
5
Period of Report
2019-07-22
Effectiveness Date
2019-06-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A odt-def14a_20190722.htm DEF 14A 1030075
2 GRAPHIC gr3s32zayarg000002.jpg GRAPHIC 6916
3 GRAPHIC gr3s32zayarg000004.jpg GRAPHIC 68150
4 GRAPHIC gr3s32zayarg000003.jpg GRAPHIC 78859
5 GRAPHIC gr3s32zayarg000001.jpg GRAPHIC 6916
  Complete submission text file 0001564590-19-023265.txt   1253446
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38318 | Film No.: 19916017
SIC: 2834 Pharmaceutical Preparations